Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.
Multiple Sclerosis from Bench to Bedside.
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
Cognitive Trajectories in 4 Patients With Pediatric-Onset Multiple Sclerosis: Serial Evaluation Over a Decade.
Multiple sclerosis: Infertility treatment increases multiple sclerosis activity.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes.
Olfactory System and Demyelination.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis (commentary).
Social and economic burden of walking and mobility problems in multiple sclerosis.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset.
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
The use of telemedicine in patients with multiple sclerosis.
Dalfampridine prior authorization program: a cohort study.
LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.
Robotic therapy: the tipping point.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity.
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Multiple sclerosis in Syria.
Immunotherapy of Neuromyelitis Optica.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Is metabolic flexibility altered in multiple sclerosis patients?

Pages